Sol-Gel Technologies (FRA:4SG) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 28, 2026)


FRA:4SG Sol-Gel Technologies Ltd FRA:4SG
53 GF Score
Price €60.00
GF Value €52.72
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sol-Gel Technologies's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:4SG vs ALEC, LENZ, CNXU: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Sol-Gel Technologies's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sol-Gel Technologies Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's Margin of Safety % (DCF Earnings Based) falls into.


FRA:4SG
53GF Score
Sol-Gel Technologies Ltd FRA:4SG
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sol-Gel Technologies (FRA:4SG) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of €60.00 is trading 13.8% above its estimated GF Value™ of €52.72. GuruFocus considers Sol-Gel Technologies to be Fairly Valued.

Key valuation signals for FRA:4SG:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €52.72 vs. price of €60.00 (13.8% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the FRA:4SG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sol-Gel Technologies Business Description

Other Exchanges SLGL:USA
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
53GF Score

Get the complete analysis for FRA:4SG

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.00
Price
€52.72
GF Value